Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide injection vs Victoza in type 2 diabetes inadequately controlled on metformin
CTR20192168Phase 3Completed
- Sponsor
- Lianyungang Runzhong
- Start
- Mar 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Lianyungang Runzhong. Started Mar 2020; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20192168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192168.